NEW YORK (Reuters Health) – Lifileucel shows promise in metastatic-melanoma patients whose disease had progressed on standard immune-checkpoint inhibitors (ICI) and other therapies, according to...

NEW YORK (Reuters Health) – Use of systemic corticosteroids to treat cutaneous immune-related adverse events (cirAEs) brought on by immune-checkpoint inhibitor (ICI) cancer therapy does not appear...